Pharmaceutical Companies
Exelixis
๐บ๐ธUnited States
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded...
Revolution Medicines
๐บ๐ธUnited States
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy...
Bachem AG
๐จ๐ญSwitzerland
ONO PHARMACEUTICAL CO
๐ฏ๐ตJapan
Jazz Pharmaceuticals
๐ฎ๐ชIreland
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product por...
Ionis Pharmaceuticals
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 927
- Market Cap
- $7B
- Website
- -
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform ...
Sinopharm
๐จ๐ณChina
LUNDBECK, LLC
๐บ๐ธUnited States
Grifols
๐ช๐ธSpain
- Ownership
- Subsidiary, Public
- Established
- 1940-01-01
- Employees
- 23.7K
- Market Cap
- $6.8B
- Website
- http://www.grifols.com
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products derivin...
Viking Therapeutics
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2012-01-01
- Employees
- 27
- Market Cap
- $6.8B
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 201...
